SCHEMBL8037857

SCHEMBL8037857

CCCc1nn(C)c2c(=O)[nH]c(N(Cc3cccc(-n4cccc4)c3)CC3CCCCC3)nc12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE5A O76074 16/20 0.42
PDE3A Q14432 4/20 0.42
PDE3B Q13370 3/20 0.42
PDE1A P54750 2/20 0.38
PDE1B Q01064 2/20 0.38
PDE1C Q14123 2/20 0.38
KMT2A Q03164 2/20 0.38
MEN1 O00255 1/20 0.38
ALDH1A1 P00352 1/20 0.38
HPGD P15428 1/20 0.38
HDAC1 Q13547 5/20 0.38
HDAC6 Q9UBN7 5/20 0.38
MTOR P42345 1/20 0.38
TERT O14746 2/20 0.38
HDAC2 Q92769 1/20 0.36
PDE6C P51160 2/20 0.35
PDE2A O00408 1/20 0.35
ABCC4 O15439 1/20 0.35
ABCC5 O15440 1/20 0.35
PDE6D O43924 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4128912 0.87 PDE5A (0.41) PDE5APDE3APDE3BPDE1APDE1B
SCHEMBL14021159 0.85 PDE5A (0.45) PDE5APDE3APDE3BPDE1APDE1B
SCHEMBL4132769 0.84 PDE5A (0.42) PDE5APDE3APDE3BPDE1APDE1B
SCHEMBL8049072 0.82 PDE5A (0.48) PDE5APDE3APDE3BPDE1APDE1B
SCHEMBL8032549 0.81 PDE5A (0.36) PDE5APDE3APDE3BPDE1APDE1B
SCHEMBL4123059 0.80 PDE5A (0.34) PDE5APDE3APDE3BHDAC1HDAC6
SCHEMBL4134650 0.79 PDE5A (0.51) PDE5APDE3APDE3BPDE1APDE1B
SCHEMBL3993298 0.78 PDE5A (0.44) PDE5APDE3APDE3BPDE1APDE1B
SCHEMBL8045086 0.78 PDE5A (0.47) PDE5APDE3APDE3BPDE1APDE1B
SCHEMBL4136868 0.78 PDE5A (0.44) PDE5APDE3APDE3BPDE1APDE1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009071706-A1 PYRAZOLEPYRIMIDINE COMPOUNDS USEFUL FOR THE TREATMENT OF DEGENERATIVE & INFLAMMATORY DISEASES GALAPAGOS NV (BE) 2009-06-11 WO disclosed